Interestingly, clarithromycin has shown potential anti-cancer properties in preclinical studies. It has been observed to induce apoptosis (programmed cell death) and inhibit cell proliferation in certain types of cancer cells. This has sparked interest in repurposing this common antibiotic as a part of cancer therapy.
